IL2 and graft versus host disease: Tregs selected using magnetic beads and primed twice by allogenic monocyte-derived DCs (mDCs) cultured with rapamycin, IL-2 and IL-15 have been shown to be functional both in vitro and in vivo, controlling GVHD in a mouse model [23].